Rockefeller Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Rockefeller Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.2K	Buy	7,148 +5,714	+398%	+$19.4K	﹤0.01%	3713
2025 Q4	$4.66K	Buy	+1,434	New	+$4.83K	﹤0.01%	4092
2023 Q1	–	Sell	-721	Closed	-$10K	–	3165
2022 Q4	$10K	Sell	721 -4,879	-87%	-$76.8K	﹤0.01%	3078
2022 Q3	$142K	Buy	+5,600	New	+$141K	﹤0.01%	1810
2022 Q2	–	Sell	-115	Closed	-$4K	–	4289
2022 Q1	$4K	Buy	115 +45	+64%	+$1.51K	﹤0.01%	3426
2021 Q4	$2K	Hold	70	–	–	﹤0.01%	3552
2021 Q3	$3K	Hold	70	–	–	﹤0.01%	3349
2021 Q2	$2K	Buy	+70	New	+$2.71K	﹤0.01%	3257

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockefeller Capital Management's MRVI Position: Q1 2026 in Review

Rockefeller Capital Management increased its Maravai LifeSciences (MRVI) stake by 398% in Q1 2026, buying an estimated $19.4K and bringing the position to 7,148 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

Rockefeller Capital Management first reported a position in MRVI in Q2 2021 and has held it in 8 quarters since. The position peaked at $142K in Q3 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Rockefeller Capital Management held 7,148 shares of Maravai LifeSciences worth $20.2K as of Q1 2026.
Rockefeller Capital Management bought 5,714 Maravai LifeSciences shares in Q1 2026, an estimated $19.4K.
Maravai LifeSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3713 holding.
Rockefeller Capital Management first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 8 quarters since.
Rockefeller Capital Management's Maravai LifeSciences position peaked at $142K in Q3 2022.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.